Update on natural killer cells: Cross-talk with dendritic cells and role in the cure of acute myeloid leukemias

[1] Immunobiology of dendritic cells [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 767 - +

[2] Dendritic cells and the control of immunity [J]. NATURE, 1998, 392 (6673) : 245 - 252

[3] Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (07) : 2231 - 2233

[4] Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO

[5] 2-O

[6] The human leukocyte antigen (HLA)-C-specific ''activatory'' or ''inhibitory'' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) : 645 - 650

[7] A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (08) : 1816 - 1824

[8] GNTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr-virus-infected B cells in X-linked lymphoproliferative disease [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (03) : 235 - 246

[9] NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) : 787 - 795

[10] Demangel C, 1999, EUR J IMMUNOL, V29, P1972, DOI 10.1002/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.3.CO

[1] Immunobiology of dendritic cells [J]. ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 : 767 - +

[2] Dendritic cells and the control of immunity [J]. NATURE, 1998, 392 (6673) : 245 - 252

[3] Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J]. JOURNAL OF IMMUNOLOGY, 2018, 200 (07) : 2231 - 2233

[4] Biassoni R, 1999, EUR J IMMUNOL, V29, P1014, DOI 10.1002/(SICI)1521-4141(199903)29:03<1014::AID-IMMU1014>3.0.CO

[5] 2-O

[6] The human leukocyte antigen (HLA)-C-specific ''activatory'' or ''inhibitory'' natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) : 645 - 650

[7] A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (08) : 1816 - 1824

[8] GNTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr-virus-infected B cells in X-linked lymphoproliferative disease [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (03) : 235 - 246

[9] NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (05) : 787 - 795

[10] Demangel C, 1999, EUR J IMMUNOL, V29, P1972, DOI 10.1002/(SICI)1521-4141(199906)29:06<1972::AID-IMMU1972>3.3.CO